Corona Remedies IPO: GMP ahead of listing signals strong debut for shares - Details here
हिंदी में सुनें
Listen to this article in Hindi
Corona Remedies IPO is set to list on December 15, 2025. Strong GMP suggests a robust debut after being oversubscribed 137.04 times.
Pharma company Corona Remedies is scheduled to begin trading on the Indian stock market on Monday, December 15, 2025. Market indicators suggest the IPO will have a strong debut.
The IPO saw significant investor interest during its three-day subscription period, with the offer being oversubscribed by 137.04 times.
Based in Gujarat, Corona Remedies focuses on the development and manufacturing of pharmaceutical products in areas such as women's healthcare and cardio-diabetes.
Grey Market Premium (GMP) Indicates Positive Listing
As of Sunday, December 14, 2025, the grey market premium (GMP) for Corona Remedies IPO is ₹295 per share. Given the IPO's upper price band of ₹1,062, market analysts anticipate the shares will list at ₹1,357 each. This represents a potential premium of 28%, according to IPO India data.
The grey market premium (GMP) serves as an early indicator of investor sentiment toward an IPO.
Shivani Nyati, Head of Wealth at Swastika Investmart Ltd, anticipates a healthy listing premium of 25% to 27% for Corona Remedies, projecting a listing price between ₹1,330 and ₹1,350 per share.
Subscription Details
Data from the BSE website indicates that the Corona Remedies IPO was heavily oversubscribed. Investors bid for 62,65,41,440 shares, which is 137.04 times the 45,71,882 shares offered.
Qualified Institutional Buyers (QIBs) showed the most substantial interest, subscribing 278.52 times the allocated shares. They bid for 35,89,39,448 shares out of the 12,88,732 shares reserved for them.
Non-Institutional Investors (NIIs) followed, subscribing 208.88 times their portion, with bids for 20,18,97,066 shares compared to the 9,66,549 shares available.
Retail investors subscribed 28.73 times the shares offered to them, bidding for 6,48,02,038 shares against the 22,55,281 shares on offer.
Key IPO Information
The Corona Remedies IPO was a book-built issue consisting entirely of an offer for sale (OFS) of shares with a face value of ₹10 each, totaling ₹655.37 crore.
The IPO was open for subscription from Monday, December 8, 2025, to Wednesday, December 10, 2025. Share allotment was finalized on December 11, 2025.
The price band for the IPO was set between ₹1,008 and ₹1,062 per share, with a lot size of 14 shares. The IPO is scheduled for listing on the Indian stock market on Monday, December 15, 2025.
